Principal Financial Group’s Seaport Therapeutics SPTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SPTX
SL
Principal Financial Group's SPTX Position: Q3 2026 in Review
Principal Financial Group reduced its Seaport Therapeutics (SPTX) stake by 9% in Q3 2026, selling an estimated $828K and leaving 377,391 shares worth $7.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
Principal Financial Group first reported a position in SPTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.01M in Q2 2026. 46 funds tracked by Wall St. Rank hold SPTX as of Q3 2026.
- Principal Financial Group held 377,391 shares of Seaport Therapeutics worth $7.61M as of Q3 2026.
- Principal Financial Group sold 37,281 Seaport Therapeutics shares in Q3 2026, an estimated $828K.
- Seaport Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #1519 holding.
- Principal Financial Group first reported a position in Seaport Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Principal Financial Group's Seaport Therapeutics position peaked at $9.01M in Q2 2026.
- 46 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q3 2026.
Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.